During the past decade, Dialysis Center of Lincoln conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dialysis Center of Lincoln" are "End Stage Renal Disease" (2 trials), "Kidney Failure, Chronic" (2 trials), "End Stage Renal Disease, Requiring Dialysis" (1 trials), "End-Stage Renal Disease" (1 trials) and "Hypertriglyceridemia" (1 trials). Many other conditions were trialed in "Dialysis Center of Lincoln" in a lesser frequency.

Most popular intervention types in "Dialysis Center of Lincoln" are "Device" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Elisio-17H dialyzer" (1 trials), "Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution" (1 trials), "NxStage System One" (1 trials), "Tablo Hemodialysis System" (1 trials) and "Theranova 400 dialyzer" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dialysis Center of Lincoln" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Dialysis Center of Lincoln". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Dialysis Center of Lincoln, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dialysis Center of Lincoln, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".